Cargando…

PeptideManager: a peptide selection tool for targeted proteomic studies involving mixed samples from different species

The search for clinically useful protein biomarkers using advanced mass spectrometry approaches represents a major focus in cancer research. However, the direct analysis of human samples may be challenging due to limited availability, the absence of appropriate control samples, or the large backgrou...

Descripción completa

Detalles Bibliográficos
Autores principales: Demeure, Kevin, Duriez, Elodie, Domon, Bruno, Niclou, Simone P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151198/
https://www.ncbi.nlm.nih.gov/pubmed/25228907
http://dx.doi.org/10.3389/fgene.2014.00305
_version_ 1782333008433381376
author Demeure, Kevin
Duriez, Elodie
Domon, Bruno
Niclou, Simone P.
author_facet Demeure, Kevin
Duriez, Elodie
Domon, Bruno
Niclou, Simone P.
author_sort Demeure, Kevin
collection PubMed
description The search for clinically useful protein biomarkers using advanced mass spectrometry approaches represents a major focus in cancer research. However, the direct analysis of human samples may be challenging due to limited availability, the absence of appropriate control samples, or the large background variability observed in patient material. As an alternative approach, human tumors orthotopically implanted into a different species (xenografts) are clinically relevant models that have proven their utility in pre-clinical research. Patient derived xenografts for glioblastoma have been extensively characterized in our laboratory and have been shown to retain the characteristics of the parental tumor at the phenotypic and genetic level. Such models were also found to adequately mimic the behavior and treatment response of human tumors. The reproducibility of such xenograft models, the possibility to identify their host background and perform tumor-host interaction studies, are major advantages over the direct analysis of human samples. At the proteome level, the analysis of xenograft samples is challenged by the presence of proteins from two different species which, depending on tumor size, type or location, often appear at variable ratios. Any proteomics approach aimed at quantifying proteins within such samples must consider the identification of species specific peptides in order to avoid biases introduced by the host proteome. Here, we present an in-house methodology and tool developed to select peptides used as surrogates for protein candidates from a defined proteome (e.g., human) in a host proteome background (e.g., mouse, rat) suited for a mass spectrometry analysis. The tools presented here are applicable to any species specific proteome, provided a protein database is available. By linking the information from both proteomes, PeptideManager significantly facilitates and expedites the selection of peptides used as surrogates to analyze proteins of interest.
format Online
Article
Text
id pubmed-4151198
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-41511982014-09-16 PeptideManager: a peptide selection tool for targeted proteomic studies involving mixed samples from different species Demeure, Kevin Duriez, Elodie Domon, Bruno Niclou, Simone P. Front Genet Genetics The search for clinically useful protein biomarkers using advanced mass spectrometry approaches represents a major focus in cancer research. However, the direct analysis of human samples may be challenging due to limited availability, the absence of appropriate control samples, or the large background variability observed in patient material. As an alternative approach, human tumors orthotopically implanted into a different species (xenografts) are clinically relevant models that have proven their utility in pre-clinical research. Patient derived xenografts for glioblastoma have been extensively characterized in our laboratory and have been shown to retain the characteristics of the parental tumor at the phenotypic and genetic level. Such models were also found to adequately mimic the behavior and treatment response of human tumors. The reproducibility of such xenograft models, the possibility to identify their host background and perform tumor-host interaction studies, are major advantages over the direct analysis of human samples. At the proteome level, the analysis of xenograft samples is challenged by the presence of proteins from two different species which, depending on tumor size, type or location, often appear at variable ratios. Any proteomics approach aimed at quantifying proteins within such samples must consider the identification of species specific peptides in order to avoid biases introduced by the host proteome. Here, we present an in-house methodology and tool developed to select peptides used as surrogates for protein candidates from a defined proteome (e.g., human) in a host proteome background (e.g., mouse, rat) suited for a mass spectrometry analysis. The tools presented here are applicable to any species specific proteome, provided a protein database is available. By linking the information from both proteomes, PeptideManager significantly facilitates and expedites the selection of peptides used as surrogates to analyze proteins of interest. Frontiers Media S.A. 2014-09-02 /pmc/articles/PMC4151198/ /pubmed/25228907 http://dx.doi.org/10.3389/fgene.2014.00305 Text en Copyright © 2014 Demeure, Duriez, Domon and Niclou. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Demeure, Kevin
Duriez, Elodie
Domon, Bruno
Niclou, Simone P.
PeptideManager: a peptide selection tool for targeted proteomic studies involving mixed samples from different species
title PeptideManager: a peptide selection tool for targeted proteomic studies involving mixed samples from different species
title_full PeptideManager: a peptide selection tool for targeted proteomic studies involving mixed samples from different species
title_fullStr PeptideManager: a peptide selection tool for targeted proteomic studies involving mixed samples from different species
title_full_unstemmed PeptideManager: a peptide selection tool for targeted proteomic studies involving mixed samples from different species
title_short PeptideManager: a peptide selection tool for targeted proteomic studies involving mixed samples from different species
title_sort peptidemanager: a peptide selection tool for targeted proteomic studies involving mixed samples from different species
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151198/
https://www.ncbi.nlm.nih.gov/pubmed/25228907
http://dx.doi.org/10.3389/fgene.2014.00305
work_keys_str_mv AT demeurekevin peptidemanagerapeptideselectiontoolfortargetedproteomicstudiesinvolvingmixedsamplesfromdifferentspecies
AT duriezelodie peptidemanagerapeptideselectiontoolfortargetedproteomicstudiesinvolvingmixedsamplesfromdifferentspecies
AT domonbruno peptidemanagerapeptideselectiontoolfortargetedproteomicstudiesinvolvingmixedsamplesfromdifferentspecies
AT niclousimonep peptidemanagerapeptideselectiontoolfortargetedproteomicstudiesinvolvingmixedsamplesfromdifferentspecies